This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wong, P. C. Articles by Timmermans, P. B. Search for Related Content PubMed PubMed Citation Articles by Wong, P. C. Articles by Timmermans, P. B.

Hypertension, Vol 19, 663-667, Copyright © 1992 by American Heart Association

ARTICLES

Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function

PC Wong, R Bernard and PB Timmermans
Du Pont Merck Pharmaceutical Company, Wilmington, Del. 19880-0400.

This study examined effects of nonpeptide angiotensin II (Ang II) receptor subtype antagonists on the interaction of sympathetic function and Ang II in pithed rats. Effects of spinal cord stimulation (0.5-4 Hz) and norepinephrine (0.3-3 micrograms/kg i.v.) on mean arterial pressure (recorded with a carotid arterial catheter), cardiac output (measured with an electromagnetic flowmeter and flow probe around the thoracic ascending aorta), total peripheral resistance, and heart rate were determined. The subtype 1-selective Ang II receptor antagonist losartan (previously known as DuP 753) at 10 mg/kg i.v. blocked the hemodynamic responses to Ang II at 1 microgram/kg i.v. It inhibited mean arterial pressure and total peripheral resistance responses but not cardiac output and heart rate responses to spinal cord stimulation. In contrast, it reduced mean arterial pressure and cardiac output responses but not total peripheral resistance and heart rate responses to intravenous norepinephrine. Given at 100 mg/kg i.v., the subtype 2- selective receptor antagonist PD123177 did not reduce hemodynamic responses to intravenous Ang II, spinal cord stimulation, and intravenous norepinephrine. These results suggest that endogenous Ang II facilitates the release of norepinephrine from sympathetic nerve terminals in the vasculature of pithed rats. Similar to the Ang II receptor in vascular smooth muscle, the prejunctional Ang II receptor in pithed rats appears to be of subtype 1.

This article has been cited by other articles:

				A. Nap, C. N. Belterman, M.-J. Mathy, J. C Balt, M. Pfaffendorf, and P. A van Zwieten Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model Journal of Renin-Angiotensin-Aldosterone System, December 1, 2003; 4(4): 220 - 227. [Abstract] [PDF]

				A. Nap, J. C Balt, M. Pfaffendorf, and P. A van Zwieten No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 100 - 105. [Abstract] [PDF]

				G. F. DiBona and S. Y. Jones Effect of Sodium Intake on Sympathetic and Hemodynamic Response to Thermal Receptor Stimulation Hypertension, February 1, 2003; 41(2): 261 - 265. [Abstract] [Full Text] [PDF]

				J. C Balt, M.-J. Mathy, A. Nap, M. Pfaffendorf, and P. A van Zwieten Involvement of the AT2-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission Journal of Renin-Angiotensin-Aldosterone System, September 1, 2002; 3(3): 181 - 187. [Abstract] [PDF]

				K. Kushiku, H. Yamada, K. Shibata, R. Tokunaga, T. Katsuragi, and T. Furukawa Upregulation of Immunoreactive Angiotensin II Release and Angiotensinogen mRNA Expression by High-Frequency Preganglionic Stimulation at the Canine Cardiac Sympathetic Ganglia Circ. Res., January 19, 2001; 88(1): 110 - 116. [Abstract] [Full Text] [PDF]

				G. F. DiBona Nervous Kidney : Interaction Between Renal Sympathetic Nerves and the Renin-Angiotensin System in the Control of Renal Function Hypertension, December 1, 2000; 36(6): 1083 - 1088. [Abstract] [Full Text] [PDF]

				S. S. Shetty and D. DelGrande Differential Inhibition of the Prejunctional Actions of Angiotensin II in Rat Atria by Valsartan, Irbesartan, Eprosartan, and Losartan J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 179 - 186. [Abstract] [Full Text]

				X.-H. Jin, Z.-Q. Wang, H. M. Siragy, R. L. Guerrant, and R. M. Carey Regulation of jejunal sodium and water absorption by angiotensin subtype receptors Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R515 - R523. [Abstract] [Full Text] [PDF]

				P. F. Dillon, R. S. Root-Bernstein, and D. D. Holsworth Augmentation of Aortic Ring Contractions by Angiotensin II Antisense Peptide Hypertension, March 1, 1998; 31(3): 854 - 860. [Abstract] [Full Text] [PDF]

				M. A. Weber, R. L. Byyny, J. H. Pratt, E. P. Faison, D. B. Snavely, A. I. Goldberg, and E. B. Nelson Blood Pressure Effects of the Angiotensin II Receptor Blocker, Losartan Arch Intern Med, February 27, 1995; 155(4): 405 - 411. [Abstract] [PDF]